287 related articles for article (PubMed ID: 21704169)
41. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
[TBL] [Abstract][Full Text] [Related]
42. Current prophylactic and therapeutic uses of a recombinant Lactococcus lactis strain secreting biologically active interleukin-12.
Bermúdez-Humarán LG; Cortes-Perez NG; Ah-Leung S; Lefèvre F; Yang G; Pang Q; Wu C; Zeng Y; Adel-Patient K; Langella P
J Mol Microbiol Biotechnol; 2008; 14(1-3):80-9. PubMed ID: 17957114
[TBL] [Abstract][Full Text] [Related]
43. Use of the usp45 lactococcal secretion signal sequence to drive the secretion and functional expression of enterococcal bacteriocins in Lactococcus lactis.
Borrero J; Jiménez JJ; Gútiez L; Herranz C; Cintas LM; Hernández PE
Appl Microbiol Biotechnol; 2011 Jan; 89(1):131-43. PubMed ID: 20842358
[TBL] [Abstract][Full Text] [Related]
44. Lactococcus lactis as a cell factory for delivery of therapeutic proteins.
Bahey-El-Din M; Gahan CG; Griffin BT
Curr Gene Ther; 2010 Feb; 10(1):34-45. PubMed ID: 20156189
[TBL] [Abstract][Full Text] [Related]
45. Lactic Acid Bacteria as Delivery Vehicle for Therapeutics Applications.
Batista VL; da Silva TF; de Jesus LCL; Tapia-Costa AP; Drumond MM; Azevedo V; Mancha-Agresti P
Methods Mol Biol; 2021; 2183():447-459. PubMed ID: 32959259
[TBL] [Abstract][Full Text] [Related]
46. Lactococcus lactis: from the dairy industry to antigen and therapeutic protein delivery.
Bahey-El-Din M; Gahan CG
Discov Med; 2010 May; 9(48):455-61. PubMed ID: 20515614
[TBL] [Abstract][Full Text] [Related]
47. Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
Bermúdez-Humarán LG
Hum Vaccin; 2009 Apr; 5(4):264-7. PubMed ID: 19202351
[TBL] [Abstract][Full Text] [Related]
48. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
Loeffler DI; Schoen CU; Goebel W; Pilgrim S
Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
[TBL] [Abstract][Full Text] [Related]
49. Salmonella-based vaccines for infectious diseases.
Kwon YM; Cox MM; Calhoun LN
Expert Rev Vaccines; 2007 Apr; 6(2):147-52. PubMed ID: 17408365
[TBL] [Abstract][Full Text] [Related]
50. Lactococcus lactis-based vaccines: current status and future perspectives.
Bahey-El-Din M; Gahan CG
Hum Vaccin; 2011 Jan; 7(1):106-9. PubMed ID: 21263226
[TBL] [Abstract][Full Text] [Related]
51. Fusion to a carrier protein and a synthetic propeptide enhances E7 HPV-16 production and secretion in Lactococcus lactis.
Bermúdez-Humarán LG; Cortes-Perez NG; Le Loir Y; Gruss A; Rodriguez-Padilla C; Saucedo-Cardenas O; Langella P; Montes de Oca-Luna R
Biotechnol Prog; 2003; 19(3):1101-4. PubMed ID: 12790689
[TBL] [Abstract][Full Text] [Related]
52. DNA vaccines against enteric infections.
Herrmann JE
Vaccine; 2006 May; 24(18):3705-8. PubMed ID: 16095769
[TBL] [Abstract][Full Text] [Related]
53. Conservation of key elements of natural competence in Lactococcus lactis ssp.
Wydau S; Dervyn R; Anba J; Dusko Ehrlich S; Maguin E
FEMS Microbiol Lett; 2006 Apr; 257(1):32-42. PubMed ID: 16553829
[TBL] [Abstract][Full Text] [Related]
54. Membrane Protein Production in Lactococcus lactis for Functional Studies.
Seigneurin-Berny D; King MS; Sautron E; Moyet L; Catty P; André F; Rolland N; Kunji ER; Frelet-Barrand A
Methods Mol Biol; 2016; 1432():79-101. PubMed ID: 27485331
[TBL] [Abstract][Full Text] [Related]
55. DNA vaccines: vector design, delivery, and antigen presentation.
Feltquate DM
J Cell Biochem Suppl; 1998; 30-31():304-11. PubMed ID: 9893284
[TBL] [Abstract][Full Text] [Related]
56. Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine.
Pascual DW; Powell RJ; Lewis GK; Hone DM
Behring Inst Mitt; 1997 Feb; (98):143-52. PubMed ID: 9382735
[TBL] [Abstract][Full Text] [Related]
57. [Co-delivery of exogenous protein and DNA into mammalian cells with Lactococcus lactis].
Li YJ; Liu HH; Zhang FC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1328-30. PubMed ID: 23232528
[TBL] [Abstract][Full Text] [Related]
58. [The NICE system as a tool for protein expression in Lactococcus lactis].
Olejnik-Schmidt A; Gronowalska A; Schmidt M
Postepy Biochem; 2013; 59(3):322-6. PubMed ID: 24364215
[TBL] [Abstract][Full Text] [Related]
59. Lactic acid bacteria as oral delivery systems for biomolecules.
Berlec A; Ravnikar M; Strukelj B
Pharmazie; 2012 Nov; 67(11):891-8. PubMed ID: 23210237
[TBL] [Abstract][Full Text] [Related]
60. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
Dietrich G; Spreng S; Gentschev I; Goebel W
Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
